{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:41:39Z","timestamp":1787244099893,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T00:00:00Z","timestamp":1408060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00432-014-1801-5","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T10:01:50Z","timestamp":1408010510000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab"],"prefix":"10.1007","volume":"141","author":[{"given":"Naoya","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuka","family":"Kitaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Sekii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Yoshio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Morota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"1801_CR1","first-page":"223","volume":"11","author":"M Aapro","year":"2000","unstructured":"Aapro M, Extermann M, Repetto L (2000) Evaluation of the elderly with cancer. Ann Oncol 11:223\u2013229","journal-title":"Ann Oncol"},{"key":"1801_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cbir.1994.1001","volume":"18","author":"MR Alison","year":"1994","unstructured":"Alison MR, Sarraf CE (1994) The role of growth factors in gastrointestinal cell proliferation. Cell Biol Int 18:1\u201310","journal-title":"Cell Biol Int"},{"key":"1801_CR3","first-page":"7350","volume":"62","author":"KK Ang","year":"2002","unstructured":"Ang KK, Berkey BA, Tu X et al (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350\u20137356","journal-title":"Cancer Res"},{"key":"1801_CR4","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1200\/JCO.2005.07.119","volume":"23","author":"J Baselga","year":"2005","unstructured":"Baselga J, Trigo JM, Bourhis J et al (2005) Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and\/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 23:5568\u20135577","journal-title":"J Clin Oncol"},{"key":"1801_CR5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/annonc\/mdr139","volume":"22","author":"J Bernier","year":"2011","unstructured":"Bernier J, Russi EG, Homey B et al (2011) Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. Ann Oncol 22:2191\u20132200","journal-title":"Ann Oncol"},{"key":"1801_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","volume":"184","author":"E B\u00f6lke","year":"2008","unstructured":"B\u00f6lke E, Gerber PA, Lammering G et al (2008) Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab. Strahlenther Onkol 184:105\u2013110","journal-title":"Strahlenther Onkol"},{"key":"1801_CR7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"1801_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"JA Bonner","year":"2010","unstructured":"Bonner JA, Harari PM, Giralt J et al (2010) Radiotherapy plus cetuximab for locally advanced head and neck cancer; 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 11:21\u201328","journal-title":"Lancet Oncol."},{"key":"1801_CR9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.6004\/jnccn.2008.0052","volume":"6","author":"B Brockstein","year":"2008","unstructured":"Brockstein B, Lacouture M, Agulnik M (2008) The role of inhibitors of the epidermal growth factor in management of head and neck cancer. J Natl Compr Cancer Netw 6:696\u2013706","journal-title":"J Natl Compr Cancer Netw"},{"key":"1801_CR10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","volume":"357","author":"W Budach","year":"2007","unstructured":"Budach W, B\u00f6lke E, Homey B (2007) Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med 357:514\u2013515","journal-title":"N Engl J Med"},{"key":"1801_CR11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello F, Tortora G (2008) EGFR antagonists in cancer treatment. N Engl J Med 358:1160\u20131174","journal-title":"N Engl J Med"},{"key":"1801_CR12","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2006.08.8005","volume":"25","author":"D Curran","year":"2007","unstructured":"Curran D, Giralt J, Harari PM et al (2007) Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25:2191\u20132197","journal-title":"J Clin Oncol"},{"key":"1801_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jnci\/djp439","volume":"102","author":"RE Eilers Jr","year":"2010","unstructured":"Eilers RE Jr, Gandhi M, Patel JD et al (2010) Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J Natl Cancer Inst 102:47\u201353","journal-title":"J Natl Cancer Inst"},{"key":"1801_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejca.2004.10.014","volume":"41","author":"R Hitt","year":"2005","unstructured":"Hitt R, Ciruelos E, Amador ML et al (2005) Prognostic value of the epidermal growth factor receptor (EGFR) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Eur J Cancer 41:453\u2013460","journal-title":"Eur J Cancer"},{"key":"1801_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","volume":"357","author":"CA Hudis","year":"2007","unstructured":"Hudis CA (2007) Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med 357:39\u201351","journal-title":"N Engl J Med"},{"key":"1801_CR16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","volume":"6","author":"ME Lacouture","year":"2006","unstructured":"Lacouture ME (2006) Mechanisms of cutaneous toxicities of EGFR inhibitors. Nat Rev Cancer 6:803\u2013812","journal-title":"Nat Rev Cancer"},{"key":"1801_CR17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-475X.2006.00179.x","volume":"15","author":"AB Lansdown","year":"2007","unstructured":"Lansdown AB, Mirastschijski U, Stubbs N et al (2007) Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Rep Reg 15:2\u201316","journal-title":"Wound Rep Reg"},{"key":"1801_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clon.2007.09.003","volume":"20","author":"HK Lord","year":"2008","unstructured":"Lord HK, Junor E, Ironside J (2008) Cetuximab is effective, but more toxic than reported in the Bonner trial. Clin Oncol 20:96","journal-title":"Clin Oncol"},{"key":"1801_CR19","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMct1114348","volume":"366","author":"DG Maloney","year":"2012","unstructured":"Maloney DG (2012) Anti-CD20 antibody therapy for B-cell lymphomas. N Engl J Med 366:2008\u20132016","journal-title":"N Engl J Med"},{"key":"1801_CR20","doi-asserted-by":"crossref","first-page":"v261","DOI":"10.1093\/annonc\/mdq197","volume":"Suppl 5","author":"DE Peterson","year":"2010","unstructured":"Peterson DE, Bensadoun RJ, Rolia F (2010) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol Suppl 5:v261\u2013v265","journal-title":"Ann Oncol"},{"key":"1801_CR21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2004.00.1792","volume":"24","author":"DG Pfister","year":"2006","unstructured":"Pfister DG, Su YB, Kraus DH et al (2006) Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol 24:1072\u20131078","journal-title":"J Clin Oncol"},{"key":"1801_CR22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2011.51","volume":"305","author":"V Ranpura","year":"2011","unstructured":"Ranpura V, Hapani S, Wu S (2011) Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis. JAMA 305:487\u2013494","journal-title":"JAMA"},{"key":"1801_CR23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/14740338.5.4.553","volume":"5","author":"MW Saif","year":"2006","unstructured":"Saif MW, Mehra R (2006) Incidence and management of bevacizumab-related toxicities in colorectal cancer. Expert Opin Drug Saf 5:553\u2013566","journal-title":"Expert Opin Drug Saf"},{"key":"1801_CR24","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2007.12.6987","volume":"25","author":"A Scope","year":"2007","unstructured":"Scope A, Aqero AL, Dusza SW et al (2007) Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol 25:5390\u20135396","journal-title":"J Clin Oncol"},{"key":"1801_CR25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2010.05.018","volume":"81","author":"G Studer","year":"2011","unstructured":"Studer G, Brown M, Salgueiro EB et al (2011) Grade 3\/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. Int J Radiat Oncol Biol Phys 81:110\u2013117","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1801_CR26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1188\/05.CJON.332-338","volume":"9","author":"M Thomas","year":"2005","unstructured":"Thomas M (2005) Cetuximab: adverse event profile and recommendations for toxicity management. Clin J Oncol Nurs 9:332\u2013338","journal-title":"Clin J Oncol Nurs"},{"key":"1801_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11547-011-0716-3","volume":"117","author":"M Valeriani","year":"2012","unstructured":"Valeriani M, Muni R, Osti MF et al (2012) Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy. Radiol Med 117:125\u2013132","journal-title":"Radiol Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1801-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1801-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1801-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T18:34:11Z","timestamp":1565721251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1801-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1801-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]}}}